Urocortin II (Mouse) (0.1mg vial)

C.J. Donaldson, S.W. Sutton, M.H. Perrin, A.Z. Corrigan, K.A. Lewis, J.E. Rivier, J.M. Vaughan, and W.W. Vale, Endocrinology, 137, 2167 (1996). (Original; Human Urocortin)

T.M. Reyes, K. Lewis, M.H. Perrin, K.S. Kunitake, J. Vaughan, C.A. Arias, J.B. Hogenesch, J. Gulyas, J. Rivier, W.W. Vale, and P.E. Sawchenko, Proc. Natl. Acad. Sci. USA, 98, 2834 (2001). (Original; Urocortin II)

S.Y. Hsu and A.J.W. Hsueh, Nat. Med., 7, 605 (2001). (Original; Stresscopin & Stresscopin Related Peptides) 

M. Million, C. Maillot, P. Saunders, J. Rivier, W. Vale, and Y. Taché, Am. J. Physiol., 282, G34 (2002). (Pharmacol.)

C. Li, J. Vaughan, P.E. Sawchenko, and W.W. Vale, J. Neurosci., 22, 991 (2002). (Histochem.) 

V. Martínez, L. Wang, J.E. Rivier, W. Vale, and Y. Taché, J. Pharmacol. Exp. Ther., 301, 611 (2002). (Pharmacol.)

F.M. Dautzenberg and R.L. Hauger, Trends Pharmacol. Sci., 23, 71 (2002). (Review)